Ronald Henckel, MD
Interventional Cardiology · Billings, MTNPI 1750510624
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,682 of the $5,910 with a category attached, or 62.3%. 16 manufacturers reported payments, led by Boston Scientific at 35.7% of the total. Reporting peaked in 2019 at $3,440 and has fallen 85.1% since, to $511 in 2025. That places this record below the midpoint for interventional cardiology clinicians in MT, where the typical reported total is $5,910.
Across 180 payments — averaging $32.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$2K
- Novartis$430
- Johnson & Johnson$267
- Abiomed$212
- E.r. Squibb & Sons, L.L.C.$203
- plus $685 from 10 others
What the payments were for
- Travel & lodging$2,22938%
- Food & beverage$3,68262%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 73 | $2,112 |
| Abbott | 16 | $2,001 |
| Novartis | 26 | $430 |
| Johnson & Johnson | 14 | $267 |
| Abiomed | 7 | $212 |
| E.r. Squibb & Sons, L.L.C. | 11 | $203 |
| Edwards Lifesciences | 5 | $181 |
| Medtronic(2 entities) | 5 | $178 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $144 |
| Pfizer | 6 | $92 |
| W. L. Gore & Associates, Inc. | 1 | $19 |
| Chiesi USA, Inc. | 1 | $18 |
| Amgen | 1 | $15 |
| Acist Medical Systems, Inc. | 1 | $15 |
| Shockwave Medical, Inc | 1 | $13 |
| Biotronik Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xience V coronary stent system$1,449
- STINGRAY$1,089
- Micra$103
- Xience Sierra Coronary Stent System$102
How this compares
$5,910 in reported general payments places this provider in the 50th percentile of 22 interventional cardiology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 70 | $83,501 |
| EliquisApixaban | 79 | $64,413 |
| JardianceEmpagliflozin | 69 | $58,973 |
| FarxigaDapagliflozin Propanediol | 57 | $43,055 |
| Repatha SureclickEvolocumab | 29 | $19,281 |
| XareltoRivaroxaban | 18 | $10,400 |
| Metoprolol Succinate | 163 | $2,399 |
| Atorvastatin Calcium | 62 | $662 |
| Ezetimibe | 39 | $644 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 65 | $629 |
| ClopidogrelClopidogrel Bisulfate | 104 | $577 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 32 | $568 |
| Carvedilol | 59 | $363 |
| Spironolactone | 77 | $343 |
| Enalapril-HydrochlorothiazideEnalapril/Hydrochlorothiazide | 12 | $288 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $430 | $83,50170 claims |
| PfizerEliquis | $92 | $64,41379 claims |
| Johnson & JohnsonXarelto | $267 | $10,40018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 22 interventional cardiology providers in Montana.
Other interventional cardiology in Billings
- Robert MinorBillings$46K
- Claudia Lama von BuchwaldBillings$29K
- Per SommerBillings$27K
- Robert TerryBillings$12K
- Shunsuke AoiBillings$3K
- Brian RahBillings$805
- Cindy TomBillings$80
- Steven GoldbergGreat Falls$134K
- Daniel SpoonMissoula$58K
- Michael EisenhauerGreat Falls$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.